About Quarterly Earnings Report Disclosures
| Item | Current | Prior | YoY % |
|---|---|---|---|
| Net Sales | ¥24.15B | ¥23.76B | +1.6% |
| Cost of Sales | ¥16.94B | ¥16.52B | +2.5% |
| Gross Profit | ¥7.21B | ¥7.24B | -0.4% |
| SG&A Expenses | ¥6.19B | ¥6.07B | +2.0% |
| Operating Income | ¥1.02B | ¥1.17B | -12.7% |
| Non-operating Income | ¥130M | ¥134M | -3.0% |
| Non-operating Expenses | ¥104M | ¥81M | +28.4% |
| Ordinary Income | ¥1.05B | ¥1.23B | -14.3% |
| Profit Before Tax | ¥1.02B | ¥1.17B | -13.1% |
| Income Tax Expense | ¥363M | ¥363M | +0.0% |
| Net Income | ¥656M | ¥809M | -18.9% |
| Net Income Attributable to Owners | ¥656M | ¥809M | -18.9% |
| Total Comprehensive Income | ¥602M | ¥846M | -28.8% |
| Depreciation & Amortization | ¥1.41B | ¥1.55B | -8.9% |
| Interest Expense | ¥22M | ¥19M | +15.8% |
| Basic EPS | ¥32.23 | ¥39.79 | -19.0% |
| Diluted EPS | ¥32.21 | ¥39.78 | -19.0% |
| Dividend Per Share | ¥0.00 | ¥0.00 | - |
| Item | Current End | Prior End | Change |
|---|---|---|---|
| Current Assets | ¥40.08B | ¥39.76B | +¥323M |
| Cash and Deposits | ¥14.73B | ¥14.66B | +¥66M |
| Accounts Receivable | ¥8.72B | ¥8.96B | ¥-237M |
| Inventories | ¥6.24B | ¥5.63B | +¥610M |
| Non-current Assets | ¥27.14B | ¥27.85B | ¥-705M |
| Item | Current | Prior | Change |
|---|---|---|---|
| Operating Cash Flow | ¥1.55B | ¥2.27B | ¥-728M |
| Financing Cash Flow | ¥-733M | ¥-726M | ¥-7M |
| Item | Value |
|---|---|
| Net Profit Margin | 2.7% |
| Gross Profit Margin | 29.9% |
| Current Ratio | 215.6% |
| Quick Ratio | 182.1% |
| Debt-to-Equity Ratio | 0.56x |
| Interest Coverage Ratio | 46.59x |
| EBITDA Margin | 10.1% |
| Effective Tax Rate | 35.6% |
| Item | YoY Change |
|---|---|
| Net Sales YoY Change | +1.6% |
| Operating Income YoY Change | -12.6% |
| Ordinary Income YoY Change | -14.3% |
| Net Income Attributable to Owners YoY Change | -19.0% |
| Total Comprehensive Income YoY Change | -28.8% |
| Item | Value |
|---|---|
| Shares Outstanding (incl. Treasury) | 20.74M shares |
| Treasury Stock | 381K shares |
| Average Shares Outstanding | 20.36M shares |
| Book Value Per Share | ¥2,115.88 |
| EBITDA | ¥2.44B |
| Item | Amount |
|---|---|
| Q2 Dividend | ¥0.00 |
| Year-End Dividend | ¥35.00 |
| Segment | Revenue | Operating Income |
|---|---|---|
| Medical | ¥48M | ¥3.00B |
| Tape | ¥36M | ¥361M |
| Item | Forecast |
|---|---|
| Net Sales Forecast | ¥51.50B |
| Operating Income Forecast | ¥3.00B |
| Ordinary Income Forecast | ¥3.10B |
| Net Income Attributable to Owners Forecast | ¥2.00B |
| Basic EPS Forecast | ¥98.25 |
| Dividend Per Share Forecast | ¥40.00 |
This data was automatically extracted from XBRL files. Please refer to the original disclosure documents for accuracy.
| Property, Plant & Equipment | ¥20.46B | ¥20.94B | ¥-485M |
| Intangible Assets | ¥659M | ¥648M | +¥11M |
| Total Assets | ¥67.22B | ¥67.60B | ¥-383M |
| Current Liabilities | ¥18.59B | ¥17.04B | +¥1.55B |
| Accounts Payable | ¥4.42B | ¥4.52B | ¥-97M |
| Non-current Liabilities | ¥5.56B | ¥7.38B | ¥-1.82B |
| Long-term Loans | ¥2.00B | ¥2.00B | ¥0 |
| Total Liabilities | ¥24.15B | ¥24.41B | ¥-269M |
| Total Equity | ¥43.07B | ¥43.19B | ¥-113M |
| Capital Stock | ¥5.45B | ¥5.45B | ¥0 |
| Capital Surplus | ¥4.19B | ¥4.19B | ¥0 |
| Retained Earnings | ¥32.42B | ¥32.48B | ¥-59M |
| Treasury Stock | ¥-642M | ¥-642M | ¥0 |
| Owners' Equity | ¥43.07B | ¥43.19B | ¥-113M |
| Working Capital | ¥21.49B | - | - |